Cancer Chemotherapy and Pharmacology

, Volume 25, Issue 3, pp 213–218 | Cite as

Haematological recovery following high-dose cyclophosphamide with autologous bone marrow transplantation

  • Christopher Twelves
  • Robert Souhami
  • Peter Harper
  • Anthony Goldstone


A total of 31 patients with previously untreated small-cell carcinoma of the lung were treated with very-high-dose cyclophosphamide, using autologous bone marrow transplantation (ABMT) to assist haematological recovery. The period of neutropenia was shorter with 40 mg/kg cyclophosphamide x 4 (7 patients) than when the dose of cyclophosphamide was increased to 50 mg/kg x 4 (11 patients), despite ABMT 2 days after chemotherapy in each group. In all, 13 patients were treated with 50 mg/kg cyclophosphamide x 4, with infusion of bone marrow delayed to day 4, 6 or 8 after chemotherapy to determine the contribution of ABMT to haematological recovery. The period of neutropaenia was increased when marrow was returned 6 days following chemotherapy, confirming that ABMT contributed to haematological recovery after this schedule of treatment. A total of 11 patients had a second cycle of 50 mg/kg cyclophosphamide x 4 after recovery from the first cycle of high-dose chemotherapy. The period of myelosuppression was greater with the second cycle of chemotherapy, although ABMT was carried out during both cycles. The results show that ABMT contributes to haematological recovery when the dose of cyclophosphamide is high enough to produce prolonged hypoplasia. The increased myelosuppression observed after a second high-dose treatment in spite of ABMT suggests either that both transplanted and endogenous marrow activity contribute to recovery of myelopoiesis or that there is residual damage to marrow stroma after the first cycle of treatment. The data indicate the necessity of carefully assessing the role of ABMT in haematological recovery with high-dose chemotherapy regimens.


Carcinoma Bone Marrow Cancer Research Neutropenia Cyclophosphamide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Appelbaum FR, Herzig GP, Ziegler JL, Graw RG, Levine AS, Deisseroth AB (1978) Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 52: 85Google Scholar
  2. 2.
    Clifford P, Clift RA, Duff JK (1961) Nitrogen-mustard therapy combined with autologous marrow infusion. Lancet I: 687Google Scholar
  3. 3.
    Dexter TM, Allen TD, Lajtha LG (1977) Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 91: 335Google Scholar
  4. 4.
    Dicke KA, Spitzer G (1986) Clinical studies of autografting in acute lymphocytic leukaemia. Clin Oncol 15: 85Google Scholar
  5. 5.
    Fried W, Barone J (1980) Residual marrow damage following therapy with cyclophosphamide. Exp Haematol 8: 610Google Scholar
  6. 6.
    Gorin NC, Najman A, Salmon CH, Muller JY, Petit JC, David R, Stachowiak J, Hirsch Marie F, Parlier Y, Duhamel G (1979) High dose combination chemotherapy (TACC) with and without autologous bone marrow transplantation for the treatment of acute leukaemia and other malignant diseases. Eur J Cancer 15: 1113Google Scholar
  7. 7.
    Gorin NC, David R, Stachowiak J, Salmon C, Petit JC, Parlier Y, Najman A, Dulhamel G (1981) High dose chemotherapy in adult leukaemias, malignant lymphomas and solid tumours. A study of 23 patients. Eur J Cancer 17: 557Google Scholar
  8. 8.
    Graham MI, Shaw IC, Souhami RL, Sidau B, Harper PG, McLean AEM (1983) Decreased plasma half-life of cyclophosphamide during repeated high-dose administration. Cance Chemother Pharmacol 10: 192Google Scholar
  9. 9.
    Linch DC, Burnett AK (1986) Clinical studies of ABMT in acute myeloid leukaemia. Clin Oncol 15: 167Google Scholar
  10. 10.
    Linch DC, Goldstone AH (1984) Autologous bone marrow transplantation. Br J Haematol 58: 1Google Scholar
  11. 11.
    Linch DC, Knott LJ, Patterson KG, Cowan DA, Harper PG (1982) Bone marrow processing and cryopreservation. J Clin Pathol 35: 186Google Scholar
  12. 12.
    Mauch PM, Botnick LE, Hannon EC, Obbagy J, Hellman S (1982) Decline in bone marrow proliferative capacity as a function of age. Blood 60: 245Google Scholar
  13. 13.
    McElwain TJ, Hedley DW, Burton G, Clink HM, Gordon MY, Jarman M, Juttner CA, Millar JL, Milsted RAV, Prentice G, Smith IE, Spence D, Woods M (1979) Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan. Br J Cancer 40: 72Google Scholar
  14. 14.
    Molineux G, Xu C, Hendry J, Testa NG (1986) A cellular analysis of long term haemopoietic damage in mice after repeated treatment with cyclophosphamide. Cancer Chemother Pharmacol 18: 11Google Scholar
  15. 15.
    Phillips GL, Reece DE (1986) Clinical studies of autologous bone marrow transplantation in Hodgkin's disease. Clin Oncol 15: 151Google Scholar
  16. 16.
    Ragab AH, Gilkerson E, Myers M (1977) Factors in the cryopreservation of bone marrow cells from children with acute lymphocytic leukaemia. Cryobiology 14: 125Google Scholar
  17. 17.
    Schuler U, Ehringer G, Wagner T (1987) Repeated high-dose cyclophosphamide administration in bone marrow transplantation. Exposure to activated metabolites. Cancer Chemother Pharmacol 20: 248Google Scholar
  18. 18.
    Shorthouse AJ, Jones JM, Steel GG, Peckham MJ (1982) Experimental combination and single-agent chemotherapy in human lung tumour xenografts. Br J Cancer 46: 35Google Scholar
  19. 19.
    Singer CRJ, Goldstone AH (1986) Clinical studies of ABMT in non-Hodgkins lymphoma. Clin Oncol 15: 105Google Scholar
  20. 20.
    Smith IE, Evans BD, Harland SJ, Millar JL (1983) Autologous bone marrow rescue is unnecessary after very high-dose cyclophosphamide. Lancet I: 76Google Scholar
  21. 21.
    Souhami RL, Peters W (1986) High-dose chemotherapy in solid tumours in adults. Clin Oncol 15: 219Google Scholar
  22. 22.
    Souhami RL, Harper PG, Linch D, Trask C, Goldstone AH, Tobias JS, Spiro SG, Geddes DM, Richards JDM (1983) High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchus. Cancer Chemother Pharmacol 10: 205Google Scholar
  23. 23.
    Souhami RL, Finn G, Gregory WM, Birkhead BG, Buckman R, Edwards D, Goldstone AH, Harper PG, Spiro SG, Tobias JS, Geddes D (1985) High-dose cyclophosphamide in small cell carcinoma of the lung. J Clin Oncol 3: 958Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • Christopher Twelves
    • 1
  • Robert Souhami
    • 1
  • Peter Harper
    • 2
  • Anthony Goldstone
    • 3
  1. 1.Department of OncologyUniversity College & Middlesex School of MedicineLondonU. K.
  2. 2.Clinical Oncology UnitGuy's HospitalLondonU. K.
  3. 3.Department of HaematologyUniversity College HospitalLondonU. K.

Personalised recommendations